Sunshine Biopharma

About:

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.

Website: http://sunshinebiopharma.com

Top Investors: RB Capital Partners

Description:

Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer. Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic that has claimed the lives of over 4 million people worldwide since it first appeared in December 2019. There are currently no drugs that can effectively arrest replication of the virus in people who have contracted the illness.

Total Funding Amount:

$21.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Montréal, Quebec, Canada

Founded Date:

2006-01-01

Contact Email:

info(AT)sunshinebiopharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-02-13

IPO Status:

Public

Industries:

© 2025 bioDAO.ai